Growing community of inventors

Lund, Sweden

Karl Henrik Johannes Ehinger

Average Co-Inventor Count = 4.29

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Karl Henrik Johannes EhingerSteven James Moss (3 patents)Karl Henrik Johannes EhingerMagnus Joakim Hansson (3 patents)Karl Henrik Johannes EhingerEskil Mats Elmer (2 patents)Karl Henrik Johannes EhingerRhonan Lee Ford (4 patents)Karl Henrik Johannes EhingerHans Georg Fliri (3 patents)Karl Henrik Johannes EhingerEskil Elmér (1 patent)Karl Henrik Johannes EhingerSarah Piel (1 patent)Karl Henrik Johannes EhingerDavid Arthur Scowen (1 patent)Karl Henrik Johannes EhingerEskil Elmer (1 patent)Karl Henrik Johannes EhingerDerek Gregory Batcheller (0 patent)Karl Henrik Johannes EhingerMats Eskil ELMÉR (0 patent)Karl Henrik Johannes EhingerKarl Fredrik Lennart SJÖVALL (0 patent)Karl Henrik Johannes EhingerSteven Moss (1 patent)Karl Henrik Johannes EhingerMagnus Joakim Hansson (1 patent)Karl Henrik Johannes EhingerKarl Henrik Johannes Ehinger (3 patents)Steven James MossSteven James Moss (29 patents)Magnus Joakim HanssonMagnus Joakim Hansson (6 patents)Eskil Mats ElmerEskil Mats Elmer (4 patents)Rhonan Lee FordRhonan Lee Ford (4 patents)Hans Georg FliriHans Georg Fliri (3 patents)Eskil ElmérEskil Elmér (2 patents)Sarah PielSarah Piel (1 patent)David Arthur ScowenDavid Arthur Scowen (1 patent)Eskil ElmerEskil Elmer (5 patents)Derek Gregory BatchellerDerek Gregory Batcheller (0 patent)Mats Eskil ELMÉRMats Eskil ELMÉR (0 patent)Karl Fredrik Lennart SJÖVALLKarl Fredrik Lennart SJÖVALL (0 patent)Steven MossSteven Moss (3 patents)Magnus Joakim HanssonMagnus Joakim Hansson (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Abliva Ab (2 from 5 patents)

2. Neurovive Pharmaceutical Ab (1 from 7 patents)


3 patents:

1. 12310940 - Cell-permeable succinate compounds

2. 11147789 - Cell-permeable succinate compounds

3. 10307389 - Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/8/2026
Loading…